Positive Phase I Data in Heart Function, Athersys (ATHX)
September 24th, 2010
No comments
ATHX’s phase I clinical trial of MultiStem(R), its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI) demonstrate that MultiStem was well tolerated at all dose levels Read more…
